|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-5-25
|
|
pubmed:abstractText |
Osteopontin (OPN) is a glycoprotein, which may play a major role in the regulation of biological phenomena. Increased levels of OPN have been linked to the presence and to the severity of atherosclerosis. This study was undertaken to assess the prognostic significance of plasma OPN levels in patients with stable ischaemic heart disease (IHD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1365-2362
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
288-93
|
|
pubmed:meshHeading |
pubmed-meshheading:20192976-Adult,
pubmed-meshheading:20192976-Aged,
pubmed-meshheading:20192976-Aged, 80 and over,
pubmed-meshheading:20192976-Angina Pectoris,
pubmed-meshheading:20192976-Biological Markers,
pubmed-meshheading:20192976-Coronary Stenosis,
pubmed-meshheading:20192976-Epidemiologic Methods,
pubmed-meshheading:20192976-Female,
pubmed-meshheading:20192976-Humans,
pubmed-meshheading:20192976-Male,
pubmed-meshheading:20192976-Middle Aged,
pubmed-meshheading:20192976-Osteopontin,
pubmed-meshheading:20192976-Prognosis
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.
|
|
pubmed:affiliation |
Attikon University General Hospital, 1 Rimini Str., 12462 Athens, Greece. pg171@hlk.forthnet.gr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
